HPN
HPN
HPN
11/22/15
Definition
A disease of vascular regulation
in which the mechanisms that
control arterial pressure within
normal range are altered
The basic explanation is that
blood pressure is elevated when
there is increased cardiac output
plus increased peripheral
vascular resistance
Pathophysiology and
Etiology
Primary or Essential
Hypertension
(Approximately 95% of patients
with hypertension)
When the diastolic pressure is
90 mm Hg or higher and other
causes of hypertension are
absent, the condition is said to
be primary hypertension.
Secondary Hypertension
Occurs approximately 5% of
patients with hypertension
secondary to pathology
Renal pathology
Congenital anomalies,
pyelonephritis, renal artery
obstruction, acute and chronic
glomerulonephritis
Renal pathology
Reduced blood flow to kidney
causes release of renin.
Renin reacts with serum
protein in liver (a2-globulin) to
angiotensin I;
this plus angiotensinconverting enzyme (ACE) to
angiotensin II that leads to
increased blood pressure
Endocrine disturbances
Pheochromocytoma a tumor
of the adrenal gland that
causes release of epinephrine
and norepinephrine and a rise
in blood pressure
Adrenal cortex tumors lead to
an increase in aldosterone
secretion (hyperaldosteronism)
and elevated blood pressure
Excess
Sodium
Intake
Fewer
Nephrons
Renal
sodium
retentio
n
Fluid
volume
Decreased
filtration
surface
Sympatheti
c nervous
system
over
activity
Genetic
alteration
Reninangiotensi
n excess
Obesity
Cell
membrane
alteration
Endothelial
factors
Hypoinsu
linemia
Venous
constriction
Preload
Blood
Pressure
Hypertensio
n
Stress
Contractility
CARDIAC
OUTPUT
Increased CO
Functional
constriction
X
And/
or
Autoregulation
Structural
hypertroph
y
PERIPHERAL
RESISTANCE Increased
PR
PATHOPHYSIOLOGY
Changes in the arteriolar bed
causing increased resistance
Abnormally increased tone in
the sensory nervous system
that originates in the vasomotor
center, causing increased
peripheral vascular resistance
Increased blood volume
resulting from renal or
hormonal dysfunction
PATHOPHYSIOLOGY
An increase in arteriolar
thickening caused by genetic
factors, leading to increased
peripheral vascular resistance
Abnormal rennin release
resulting in the formation of
angiotensin II, which constricts
the arterioles and increased
blood volume
STAGES OF
HYPERTENSION
SBP
mmHg
DBP
mmHg
Lifestyle
Modificatio
n
Without
Compelling
Indication
With Compelling
Indication
Normal
<120
And <80
Encourage
Prehypertension
120-139
Or 80-89
Yes
No
antihypertensi
ve drug
indicated
Drug/s for
compelling
indications
Stage1
Hypertension
140-159
Or 90-99
Yes
Thiazide-type
diuretics for
most.
May consider
ACEI,ARB,BB,C
CB or
combination
Stage2
Hypertension
> 160
Or > 100
Yes
Two-drug
combination
for most.
(Usually
thiazide-type
diuretic and
ACEI or ARB or
BB or CCB
Other
antihypertensive
drugs (diuretics,
ACEI,ARB,BB,CCB
) as needed
Classification of
Hypertension
Essential/ Idiopathic/ Primary
Hypertension
Secondary Hypertension
Malignant Hypertension
Labile Hypertension
Resistant Hypertension
White Coat Hypertension
Hypertensive Crisis
RISK FACTORS
Modifiable Risk Factors :
Cigarette smoking
Diabetes mellitus
Elevated serum lipid levels
Sedentary lifestyle
Stress
Obesity
Alcohol Intake
Excessive intake of dietary fats,
carbohydrates and salt
RISK FACTORS
Non Modifiable Risk Factors :
Age
Male gender
Family history
Race
COMPLICATIONS
COMPLICATIONS
Cardiac complications include
CAD, angina, MI, heart failure,
arrhythmias and sudden death.
Neurologic complications
include stroke and hypertensive
encephalopathy.
COMPLICATIONS
Brain
Cerebral
Perfusion
TIA
Thrombosis
Aneurysms
Hemorrhage
Cardiac output
Oxygen
Supply
High Blood
Pressure
(>140/90)
Peripheral
Vascular
Resistance
Heart
Myocardial
Workload
Ventricular
Hypertrophy
Ischemia
Angina
MI
Heart Failure
Myocardial
Oxygen
Consumption
Kidney
Blood
flow
Oxygen
Renin + aldosterone
secretion
Na and H2O
reabsorption
Blood Volume
GFR
Azotemia
Failure
DIAGNOSTIC PROCEDURES
Urinalysis:
May show protein, red blood
cells or white blood cells
suggesting renal disease;
Glucose suggesting diabetes
mellitus
Excretory urography:
May reveal renal atrophy,
indicating chronic renal disease.
DIAGNOSTIC PROCEDURES
Serum potassium:
Decreased in primary
hyperaldoteronism;
elevated in Cushings
syndrome both causes of
secondary hypertension
PREVENTION
Primary prevention:
Moderation on sodium intake
PREVENTION
Decreased saturated fats diet
PREVENTION
Maintenance of IBW
PREVENTION
Maintenance of regular pattern
of exercise
PREVENTION
Cessation of cigarette smoking
PREVENTION
Stress reduction through
effective coping strategies
Medical Management
Lifestyle Modification
Lose weight if body mass index
(BMI) is greater than or equal to
27
Limit alcohol no more than 1
oz ethanol daily for men, 0.5 oz
for women
Get regular exercise equivalent
to 30 to 45 minutes of brisk
walking most days.
Drug therapy
Considerations in selecting
therapy include:
a. Race African Americans
respond well to diuretic therapy;
Caucasians responds well to ACE
inhibitors
b. Age some side effects may
not be tolerated well by elderly
persons.
Pharmacologic Agents:
Diuretics - lower blood pressure
by promoting urinary excretion
of water and sodium to lower
blood volume.
Loop diuretics:
Furosemide
K-sparing diuretics:
Spirolactone
Triamterene
Drug
Trade Name
Usual Dose
Range in Total
mg/day
(frequency per
day)
Central aAgonists
Clonidine
Catapres
0.2-1.2 (2-3)
A-Blockers
Doxazosin
mesylate
Cardura
1-16 (1)
Postural hypertension
B-Blockers
Acebutolol
Sectral
200-800 (1)
Bronchospasm, bradycardia,
heart failure, may mask
insulin-induced
hypoglycemia; less serious;
impaired peripheral
circulation, insomia, fatigue,
decreased exercise
tolerance,
hypertriglyceridemia
Direct
Vasodilators
Hydralazine
Apresoline
50-300 (2)
Calcium
Antagonists
Diltiazem HCl
Cardizem SR,
Cardizem CD,
Dilacor XR,
Tiazac
120-360 (2)
Conduction defects,
worsening of systolic
dysfunction, gingival
hyperplasia
AngiotenrinConverting
Capoten
25-150 (2-3)
Angiotensin II
Receptor Blockers
Irbersartan
Avapro
150-300 (1)
Angioedema (very
rare),
hyperkalemia
Diuretics
Hydrochlorothiazid
e (G)
HYdroDIURIL.
Microzide, Esidrix
12.5-50 (1)
Biochemical
abnormalities:
decreases
potassium,
sodium, and
magnesium levels,
increases uric acid
and calcium levels
Loop Diuretics
Furosimide (G)
Lasix
40-240 (2-3)
(Short duration of
action no
hypercalcemia)
Potassium-Sparing
Agents
Spironolactone (G)
Aldactone
25-100 (1)
(gynecomastia)
Adrenergic
Inhibitors
Peripheral Agents
Guanadrel
Hylorel
10-75 (2)
(Postural
hypotension,
diarrhea)
Coreg
12.5-50 (2)
Postural
hypotension,
bronchospasm
TREATMENT
Pharmacologic Management:
ACE Inhibitors
A II Receptor Blockers
Alpha-adrenergic Blockers
Beta-adrenergic Blockers
Calcium Antagonist
Diuretics
Complications
Angina pectoris or MI due to
decreased coronary perfusion.
Left ventricular hypertrophy and
CHF due to consistently elevated
aortic pressure.
Renal failure due to thickening of
renal vessels and diminished
perfusion to the glomerulus.
Brain
Cerebral
Perfusion
TIA
Thrombosis
Aneurysms
Hemorrhage
Cardiac output
Oxygen
Supply
High Blood
Pressure
(>140/90)
Peripheral
Vascular
Resistance
Heart
Myocardial
Workload
Ventricular
Hypertrophy
Ischemia
Angina
MI
Heart Failure
Myocardial
Oxygen
Consumption
Kidney
Blood flow
Oxygen
Renin + aldosterone
secretion
Na and H2O
reabsorption
Blood Volume
GFR
Azotemia
Failure
Nursing Assessment
Nursing History
Query the patient with regard to
the following:
Family history of high blood
pressure
Previous episodes of high blood
pressure
Dietary habits and salt intake
Cigarette smoking
Medication that could elevate
blood pressure:
Oral contraceptives, steroids
NSAIDs
Nasal decongestants, appetite
suppressants, tricyclic
antidepressants
Episodes of headache,
weakness, muscle cramps,
tingling, palpations, sweating,
visual disturbances
Other disease processes, such as
gout, migraines, asthma, heart
failure, and benign prostatic
hypertrophy, that may be helped
or worsened by particular
hypertension drugs.
NURSING CARE
PLAN:
Physical Assessment
Auscultate heart rate and
palpate peripheral pulses;
determine respirations.
If skilled in doing so, perform
funduscopic examination of the
eyes for the purpose of noting
vascular changes.
Look for edema, spasm, and
hemorrhage of the eye
vessels.
First diastolic:
The pressure within the cuff
indicated by the level of the
mercury column at the
moment when the sound
becomes muffed
Second diastolic:
The pressure within the cuff
at the moment the sound
disappears.
NURSING CARE
MANAGEMENT:
Nursing Diagnosis:
Deficient Knowledge regarding
the relationship of the treatment
regimen and control of the
disease process.
Ineffective Management of
Therapeutic Regimen related to
medication side effects and
difficult lifestyle adjustments
Goal:
The major goal include patients
understanding the disease
process and its treatment,
compliance with the self-care
program and absence of
complications
Outcome-Based Evaluation
Demonstrates increased
knowledge about high blood
pressure, medication effects,
and prescribed therapeutic
activities
Takes medications, keeps followup appointments
THE END